All the Active Ingredient Drugs
Gilteritinib (as fumarate) 40 mg. F.C. TABS.: 84. Gilteritinib may be re init. in pts. follow. haematopoietic stem cell transplantation (HSCT). The recomm. start. dose is 120 mg gilteritinib (three 40 mg tabs.) once dly. Tmt. should cont.until the pt. is no longer clinical. benefiting from Gilteritinib or until unacceptab. toxicity occurs. Response may be delayed; therefore, cont. of tmt. at the prescribed dose for up to 6 months should be consid. to allow time for a clinical response. In the absence of a response (pt. did not achieve a CRc) after 4 wks. of tmt., the dose can be incr.to 200 mg (five 40 mg tabs.) once dly., if tolerated or clinically warranted. See lit. Indicated as monother. for the tmt. of adult pts. who have relapsed or refractory acute myeloid leukaemia (AML) with a FLT3 mutation.
C/I: Hypersens.
